Previous 10 | Next 10 |
Assertio Holdings (NASDAQ:ASRT) gains 10.4% after-hours following an announcement that it has acquired Otrexup (methotrexate) from Antares Pharma (NASDAQ:ATRS). Under the terms of the agreements, Antares will receive an initial payment of $18M at closing plus two additional tim...
Trailing 12 Month Reported Revenues of Otrexup Were $15.5 Million Assertio will Pay Antares $18.0 Million Upfront and an Additional $26.0 Million in Deferred Payments Raises Full Year Net Product Sales and Non-GAAP Adjusted EBITDA Guidance LAKE FOREST, Ill., Dec....
Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day December Micro Cap Virtual Conference takin...
Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand for hosting North America’s largest independent investor conferences. Over 90 pre...
The shares of commercial pharmaceutical company Assertio Therapeutics (ASRT) have slumped more than 40% in price year-to-date. But the stock gained momentum after the company reported better-than-expected earnings last week. So, considering unfavorable analyst expectations, can the stock sust...
The following slide deck was published by Assertio Holdings, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Assertio Holdings, Inc. 2021 Q3 - Results - Earnings Call Presentation
A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Sidoti & Company, LLC has updated its preliminary list of presenting companie...
ReWalk Robotics (NASDAQ:RWLK) +44% FDA awards breakthrough device designation to the ReWalk reBoot Soft exo-suit Borr Drilling (NYSE:BORR) +31% on Q3 earnings. Assertio Holdings (NASDAQ:ASRT) +22% on Q3 earnings. Ontrak (NASDAQ:OTRK) +20% on Q3 earnings. Big...
Assertio Holdings, Inc. (ASRT) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Max Nemmers – Head-Investor Relations and Administration Dan Peisert – President and Chief Executive Officer Paul Schwichtenberg – Senior Vice President and Ch...
Assertio Therapeutics (NASDAQ:ASRT): Q3 GAAP EPS of $0.08 beats by $0.24. Revenue of $25.47M (-26.2% Y/Y) beats by $3.43M. Press Release FY21 Guidance: GAAP net product sales is seen in the range of more than $103M vs. prior $91.0 - $96.0M while adj. EBITDA is seen greater than $43M vs. ...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will rel...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...